By Editor , 24 September 2026
Astellas Doses First Patient in Phase 3 Lung Cancer Trial of Setidegrasib

Tokyo – September 24, 2026 -- Astellas Pharma Inc. (TSE: 4503) has dosed the first patient in a Phase 3 study evaluating setidegrasib, an investigational KRAS G12D-targeted protein degrader, against docetaxel in previously treated non-small cell lung cancer (NSCLC) patients carrying the KRAS G12D mutation.

By Editor , 21 September 2026
Axcelis to Showcase SiC Implantation Tech at ICSCRM 2026 in Japan

Beverly, Mass. – September 21, 2026 -- Axcelis Technologies (NASDAQ: ACLS) will exhibit at the 23rd International Conference on Silicon Carbide and Related Materials (ICSCRM 2026), targeting a silicon carbide device market Yole Group projects to reach $11 billion by 2031, expanding at a 20% compound annual growth rate from 2025 to 2031.

By Editor , 21 September 2026
FDA Grants Priority Review to Insmed's ARIKAYCE Full Approval Bid

Bridgewater, N.J. – September 21, 2026 -- The U.S. Food and Drug Administration has accepted Insmed Incorporated's supplemental New Drug Application (sNDA) for full approval of ARIKAYCE (amikacin liposome inhalation suspension) to treat Mycobacterium avium complex (MAC) lung disease, granting Priority Review with a PDUFA target action date of January 28, 2027.

By Editor , 19 September 2026

Valby, Denmark – – September 18, 2026 -- H. Lundbeck A/S has secured marketing authorization from Japan's Ministry of Health, Labour and Welfare for eptinezumab, branded Vyepti, as a preventive treatment for migraine attacks in adults, opening the company's first independent product launch in the country.

By Editor , 19 September 2026

Kyoto – September 18, 2026 -- ROHM Co., Ltd. has developed the RS4P063BPHZG, a 100V MOSFET delivering approximately five times the Safe Operating Area (SOA) tolerance of standard equivalent-sized products under VDS=100V and PW=100 microseconds.

By Editor , 19 September 2026

Tokyo – September 18, 2026 -- The Global Health Innovative Technology (GHIT) Fund has launched NTDpedia, a digital encyclopedia targeting the awareness gap that keeps neglected tropical diseases (NTDs) underfunded despite affecting 1.5 billion people worldwide.

By Editor , 17 September 2026
Fujitsu to Launch Made-in-Japan MONAKA CPU, AI Server in November 2026

Kawasaki, Japan – September 16, 2026 -- Fujitsu Limited will begin global sales of its next-generation FUJITSU-MONAKA CPU in November 2026, targeting cloud providers, data center operators and server vendors with a processor designed to double AI inference throughput while halving server count and power consumption for equivalent workloads.

By Editor , 17 September 2026

Tokyo – September 16, 2026 -- Japan's Ministry of Economy, Trade and Industry will stage the Global Startup EXPO 2026 in Osaka from October 5 to 7, opening a direct channel for overseas venture capital firms into the country's startup and investment ecosystem.